Cargando…

SNCA-AS1 in aging and Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Carelli, Stephana, Rey, Federica, Cereda, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085241/ https://www.ncbi.nlm.nih.gov/pubmed/35438650 http://dx.doi.org/10.18632/aging.204025

Ejemplares similares

α‐Synuclein antisense transcript SNCA‐AS1 regulates synapses‐ and aging‐related genes suggesting its implication in Parkinson's disease
por: Rey, Federica, et al.
Publicado: (2021)

Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications
por: Pandini, Cecilia, et al.
Publicado: (2023)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases
por: Bordoni, Matteo, et al.
Publicado: (2018)

Alzheimer’s, Parkinson’s Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement
por: Garofalo, Maria, et al.
Publicado: (2020)

Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
por: Bordoni, Matteo, et al.
Publicado: (2020)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians
por: Huang, Yue, et al.
Publicado: (2015)

Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
por: Lucchini, Roberto G., et al.
Publicado: (2020)

Advances in Tissue Engineering and Innovative Fabrication Techniques for 3-D-Structures: Translational Applications in Neurodegenerative Diseases
por: Rey, Federica, et al.
Publicado: (2020)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Festination Correlates with SNCA Polymorphism in Chinese Patients with Parkinson's Disease
por: Zheng, Jinhua, et al.
Publicado: (2017)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

SNCA 3′ UTR Genetic Variants in Patients with Parkinson’s Disease
por: Blažeković, Antonela, et al.
Publicado: (2021)

SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023)

LncRNAs Associated with Neuronal Development and Oncogenesis Are Deregulated in SOD1-G93A Murine Model of Amyotrophic Lateral Sclerosis
por: Rey, Federica, et al.
Publicado: (2021)

Neural Precursor Cells Expanded Inside the 3D Micro-Scaffold Nichoid Present Different Non-Coding RNAs Profiles and Transcript Isoforms Expression: Possible Epigenetic Modulation by 3D Growth
por: Messa, Letizia, et al.
Publicado: (2021)

The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
por: Siddiqui, Irum Javaid, et al.
Publicado: (2016)

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
por: Bras, Jose, et al.
Publicado: (2008)

Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration
por: Carelli, Stephana, et al.
Publicado: (2018)

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
por: Trotta, Luca, et al.
Publicado: (2012)

A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease
por: Zhang, Yuan, et al.
Publicado: (2018)

The Effects of SNCA rs894278 on Resting-State Brain Activity in Parkinson’s Disease
por: Zhang, Kailin, et al.
Publicado: (2019)

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects
por: Rey, Federica, et al.
Publicado: (2021)

Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease
por: Yong, Alisa CW, et al.
Publicado: (2020)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

HuR interacts with lincBRN1a and lincBRN1b during neuronal stem cells differentiation
por: Carelli, Stephana, et al.
Publicado: (2019)

Exon Dosage Variations in Brazilian Patients with Parkinson’s Disease: Analysis of SNCA, PARKIN, PINK1 and DJ-1 Genes
por: Moura, Karla Cristina Vasconcelos, et al.
Publicado: (2012)

Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson’s disease cohort
por: Loesch, Douglas P., et al.
Publicado: (2022)

Four Copies of SNCA Responsible for Autosomal Dominant Parkinson's Disease in Two Italian Siblings
por: Ferese, Rosangela, et al.
Publicado: (2015)

Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation
por: Martikainen, Mika H., et al.
Publicado: (2015)

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
por: Cooper, Christine A., et al.
Publicado: (2016)

Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease
por: Zafar, Faria, et al.
Publicado: (2018)

Genetic Impact on Clinical Features in Parkinson's Disease: A Study on SNCA-rs11931074
por: Shu, Li, et al.
Publicado: (2018)

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review
por: Campêlo, Clarissa Loureiro das Chagas, et al.
Publicado: (2017)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fprim8n2gcm9cae5kco7egi0sk